Economic Evaluation of anti-epileptic Medicines for Autistic Children with Epilepsy

被引：1

作者：

Tinelli, Michela M. ^{[1
]}

Roddy, Aine ^{[1
,7
]}

Knapp, Martin ^{[1
]}

Arango, Celso ^{[2
]}

Mendez, Maria Andreina ^{[2
]}

Cusack, James ^{[3
]}

Murphy, Declan ^{[4
]}

Canitano, Roberto ^{[5
]}

Oakley, Bethany ^{[4
]}

Quoidbach, Vinciane ^{[6
]}

机构：

[1] London Sch Econ & Polit Sci, Care Policy & Evaluat Ctr, London, England

[2] Univ Complutense, Hosp Gen Univ Gregorio Maranon, Inst Psychiat & Mental Hlth, Sch Med,Dept Child & Adolescent Psychiat,CIBERSAM,, Madrid, Spain

[3] Autistica, London, England

[4] Kings Coll London, London, England

[5] Azienda Osped Univ Senese, Azienda, Siena, Italy

[6] European Brain Council, Brussels, Belgium

[7] Atlantic Technol Univ, Sligo, Ireland

来源：

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS | 2024年 / 54卷 / 07期

基金：

欧盟地平线“2020”;

关键词：

Autism; Epilepsy; Children; Cost-effectiveness; Healthcare expenditure; Family impacts; COST-EFFECTIVENESS; ACTIVE EPILEPSY; YOUNG-ADULTS; CARE COSTS; CHILDHOOD; HEALTH; CONSEQUENCES; EDUCATION; DISORDER; IMPACT;

D O I：

10.1007/s10803-023-05941-8

中图分类号：

B844 [发展心理学（人类心理学）];

学科分类号：

040202 ;

摘要：

We examine the cost-effectiveness of treating epilepsy with anti-epileptic medicines in autistic children, looking at impacts on healthcare providers (in England, Ireland, Italy and Spain) and children's families (in Ireland). We find carbamazepine to be the most cost-effective drug to try first in children with newly diagnosed focal seizures. For England and Spain, oxcarbazepine is the most cost-effective treatment when taken as additional treatment for those children whose response to monotherapy is suboptimal. In Ireland and Italy, gabapentin is the most cost-effective option. Our additional scenario analysis presents the aggregate cost to families with autistic children who are being treated for epilepsy: this cost is considerably higher than healthcare provider expenditure.

引用

页码：2733 / 2741

页数：9

共 50 条

[1] EVALUATION OF ANTI-EPILEPTIC DRUGS IN DOGS WITH EPILEPSY
SCHWARZPORSCHE, D
LOSCHER, W
FREY, HH
SCHMIDT, D
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1983, 33-2 (07): : 1004 - 1005
[2] Epilepsy, anti-epileptic drugs and bone health in children
Gude, Dilip
JOURNAL OF PEDIATRIC NEUROSCIENCES, 2011, 6 (01) : 93 - 93
[3] Electrophysiological evaluation of children from mothers with epilepsy using anti-epileptic drugs
Guveli, B.
Gurses, C.
Bebek, N.
Baykan, B.
Gokyigit, A.
JOURNAL OF NEUROLOGY, 2007, 254 : 129 - 129
[4] Evaluation of the effect of anti-epileptic drugs on serum immunoglobulin levels in children with epilepsy
Kalantari, Arash
Hosseini, Seyed Ahmad
Bagheri, Zeynab
IMMUNOPATHOLOGIA PERSA, 2024, 10 (01):
[5] Evaluation of Effect of Anti-Epileptic Medicines on Cognitive Performance in Patients
Kinage, Parag
Khan, Huma
Dudhgaonkar, Sujata
Mahajan, Manali
Wankhede, Sumit
INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 : S88 - S88
[6] Less than Half of Children take their Anti-Epileptic Medicines as prescribed
Kreutzkamp, Barbara
PSYCHOPHARMAKOTHERAPIE, 2011, 18 (04): : 184 - 186
[7] Aggravation of epilepsy by anti-epileptic drugs
Gayatri, NA
Livingston, JH
DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2006, 48 (05): : 394 - 398
[8] Evaluation of the Response of Different Anti-epileptic Drugs in Children with SCN2A-related Epilepsy
O'Connor, J.
Gobeck, E.
Bryant, E.
Laux, L.
Berg, A.
Millichap, J.
ANNALS OF NEUROLOGY, 2018, 84 : S339 - S340
[9] Anti-Epileptic Drug Prescribing And Prevalence Of Epilepsy In New Zealand Children
Ali, S.
Stanley, J.
Scheffer, I. E.
Sadleir, L. G.
EPILEPSIA, 2019, 60 : 160 - 160
[10] Prescribing pattern of anti-epileptic and concomitant drugs in children with epilepsy in India
Dasari, Anil
Bhansal, Dipika
Azad, Chandrika
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 153 - 154

← 1 2 3 4 5 →